Clinical Trial Update: A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating Loncastuximab Tesirine in combination with Rituximab (Lonca-R) for previously untreated unfit/frail patients with Diffuse Large B-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Loncastuximab tesirine (loncastuximab tesirine)
• Rituximab (rituximab)

Snippet

Sponsor: ADC Therapeutics S.A. | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2025-01-30